Metallo- β - lactamase producing nonfermentative gram-negative bacteria: An increasing clinical threat among hospitalized patients

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 9, 2012, Pages 718-721

  Gupta, Varsha ^a   Sidhu, Shailpreet ^a   Chander, Jagdish ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Carbapenem imipenem; Metallo lactamases; Non fermentative gram negative bacilli

Indexed keywords

AMIKACIN; CEFOPERAZONE; CIPROFLOXACIN; EDETIC ACID; IMIPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULPERAZON;

ACINETOBACTER; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COMBINED DISK TEST; DISK DIFFUSION; DOUBLE DISK SYNERGY TEST; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; IMIPENEM; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84863862988     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60113-8     Document Type: Article

References (25)

1. Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC Simple screening tests for detection of carbapenemases in clinical isolates of non-fermentative gram-negative bacteria. Indian J Med Res 2009, 129:707-712.
2. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo-β- lactamase in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001, 45:2224-2228.
3. Walsh TR, Toleman MA, Poirel L, Nordmann P Metallo-β-lactamases, the quiet before the storm?. Clin Microbiol Rev 2005, 18:306-325.
4. Nordmann P, Poirel L Emerging carbapenemases in gram negative aerobes. Clin Microbiol Infect 2002, 8:321-331.
5. Bush K New β- lactamases in gram negative bacteria: diversity and impact on the selection of antimicrobial chemotherapy. Clin Infect Dis 2001, 32:1085-1089.
6. Winn WC, Allen SD, Janda WM, Koneman E, Procop GW, Schreckenberger PC, et al. The nonfermentative gram-negative bacilli. Color atlas and textbook of diagnostic microbiology 2006, 303-391. JB Lippincott Co, Philadelphia. 6th ed.
7. Moussa A, Noureddine D, Abdelmelek M, Saad A Antibacterial activity of various honey types of Algeria against Pathogenic Gram-Negative Bacilli: Escherichia coli and Pseudomonas aeruginosa. Asian Pac J Dis 2012, 2(3):211-214.
8. Clinical Laboratories Standards Institute Performance standards for antimicrobial disks susceptibility tests. Approved standards, 9th ed. CLSI document M2-A9 2006, CLSI, CLSI, Wayne, PA.
9. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y Imipenem-EDTA disk method for differentiation of metallo-β-lactamases producing clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. J Clin Microbiol 2002, 40:3798-3801.
10. Lee K, Lim YS, Yong D, Yum JH, Chong Y Evaluation of the Hodge test and the imipenem-EDTA double disk synergy test for differentiation of metallo-β-lactamases producing clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. J Clin Microbiol 2003, 41:4623-4629.
11. Walsh TR, Bolmstrom A, Quarnstrom A, Gales A Evaluation of a new E test for detecting metallo-β-lactamases in routine clinical setting. J Clin Microbiol 2002, 40:2755-2759.
12. Jesudason MV, Kandathil AJ, Balaji V Comparison of two methods to detect carbapenemases and metallo-β-lactamase production in clinical isolates. Indian J Med Res 2005, 121:233-237.
13. Cornaglia G, Riccio ML, Mazzariol A, Lauretti L, Fontana R, Rossolini GM Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 1999, 353:899-900.
14. Woodford N, Palepou MF, Babini GS, Bates J, Livermore DM Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet 1998, 352:546-547.
15. Sinha M, Srinivas H Mechanism of resistance to carbapenems in meropenem resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol 2007, 25:21-25.
16. Gupta E, Mohanty S, Sood S Emerging resistance to carbapenems in a tertiary care hospital in noeth India. Indian J Med Res 2006, 124:95-98.
17. Behera B, Mathur P, Kapil A, Sharma V An evaluation of four different phenotypic techniques for detection of metallo-β-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol 2008, 26:233-237.
18. Ozgumus OB, Caylon R, Tosun I, Sandalli C, Aydin K, Koksal I Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-β-lactamases gene in a university hospital in Turkey. Microbiol Drug Resist 2007, 13:191-198.
19. Quale J, Bratu S, Landman D, Heddurshetti R Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York city. Clin Infect Dis 2003, 37:214-220.
20. Peleg AY, Franklin C, Bell JM, Spelman DW Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Infect Control Hosp Epidemiol 2006, 27:759-761.
21. Gupta V, Datta P, Chander J Prevelance of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in a tertiary care hospital in India. J Infect 2006, 52:311-314.
22. Agarwal VA, Dondre SA, Powar RM Antimicrobial resistance profile of metallo-β-lactamase Pseudomonas aeruginosa producing metallo-β lactamases. Indian J Med Res 2006, 124:588-590.
23. Pitout JDD, Gregson DB, Poirel L, McClure JA, Le P, Church DL Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol 2005, 43:3129-3135.
24. Berges L, Rodrigues H, Deplano A, Struelens MJ Prospective evaluation of imipenem-EDTA combined disk and E test for detection of metallo-β-lactamase producing Pseudomonas aeruginosa. J Antimicrob Chemother 2007, 59:812-813.
25. Livermore DM, Woodford N Carbapenemases: a problem in waiting?. Curr Opin Microbiol 2000, 3:489-495.